Kezar Life Sciences, Inc. (KZR): Price and Financial Metrics
KZR Price/Volume Stats
| Current price | $4.40 | 52-week high | $9.18 |
| Prev. close | $4.38 | 52-week low | $3.62 |
| Day low | $4.40 | Volume | 18,600 |
| Day high | $4.49 | Avg. volume | 30,281 |
| 50-day MA | $4.28 | Dividend yield | N/A |
| 200-day MA | $6.06 | Market Cap | 32.15M |
KZR Stock Price Chart Interactive Chart >
Kezar Life Sciences, Inc. (KZR) Company Bio
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of small molecule therapeutics to treat unmet needs in autoimmunity and cancer in the United States. Its lead product candidate, KZR-616, a selective immunoproteasome inhibitor that is in Phase 1b/2 clinical trials in lupus and lupus nephritis The company was incorporated in 2015 and is headquartered in South San Francisco, California.
KZR Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
KZR Price Returns
| 1-mo | 6.80% |
| 3-mo | -27.87% |
| 6-mo | -36.69% |
| 1-year | -35.74% |
| 3-year | -91.67% |
| 5-year | -92.97% |
| YTD | -34.52% |
| 2024 | -29.07% |
| 2023 | -86.54% |
| 2022 | -57.89% |
| 2021 | 220.31% |
| 2020 | 30.17% |